News Digest / Ticker: LQDA

Ticker: LQDA

07:02am, Tuesday, Aug 12, 2025

Liquidia launches FDA-approved YUTREPIA, posts initial sales amid heavy losses and legal risk

Snapshot - Liquidia Corporation (NASDAQ: LQDA) What's happening inside: FDA approved YUTREPIA on May 23, 2025 and Liquidia commercially launched it on June 2, 2025. The company has moved from R&D focus into commercialization (hiring, inventory build, sales shipments) and drew additional funding u...

09:24am, Monday, Jun 02, 2025

Liquidia Technologies Soars 9.6% as YUTREPIA™ Set to Transform PAH Treatment Landscape Following Favorable Legal Win

08:47am, Monday, Aug 19, 2024

FDA's Curveball: Liquidia Corporation's Stock Plummets 40% Amid Regulatory Setbacks While United Therapeutics Soars